Rapid Novor Inc., is the world's leader in antibody protein sequencing technology. Specializing in the field of mass spectrometry-based proteomics. We seek to elevate human health by decoding immunity. The technology we’ve developed for sequencing and characterizing proteins using mass spectrometry has already made an extraordinary impact on antibody discovery and development. With a team of 70+ and 8000 successful projects under our belt, Rapid Novor has a strong reputation for service excellence. Our clients routinely use our services in therapeutic discovery, IVD development, basic research, controls and assay development. Our scope of services continues to expand into a full suite of R&D programs including Antibody Discovery, epitope mapping, kinetic analysis, and glycan profiling.
Something looks off?